Alcami Appoints New Chairman and CEO
Patrick D. Walsh will take over the role from Walter J. Kaczmarek III, who is stepping down as CEO.
Alcami announced on March 18, 2021 that its board of directors has named Patrick D. Walsh as its new chairman and CEO. Walsh will take over the role from Walter J. Kaczmarek III, who is stepping down as CEO.
Before joining Alcami, Walsh served as CEO of AAIPharma Services, a predecessor company to Alcami, from 2010 to 2014; CEO of Avista Pharma from 2015 to 2019; and most recently served as co-founder and CEO of TriPharm Services, a parenteral manufacturing business, according to an Alcami press release. Along with his duties at Alcami, Walsh currently serves as chairman of ANI Pharmaceuticals, a director at Landec Corporation, and a director at Industria Chemica Emiliano.
"Patrick's impressive track record of driving growth and achieving high client satisfaction at leading pharmaceutical businesses makes him the ideal executive to lead Alcami forward,” said Jason Shideler, a managing director on Madison Dearborn Partners’ Health Care team and lead director at Alcami, in the press release. “He brings a depth of industry knowledge and leadership experience that will support Alcami’s strategic efforts to continue to add scale in attractive growth markets and deliver high-quality services to the pharmaceutical industry.”
"I have long-admired Alcami for its excellent regulatory track record and ability to solve complex product development and manufacturing challenges,” Walsh added in the press release. “I look forward to working with the talented team at Alcami as we continue to expand its footprint and build upon its services offerings."
Source: Alcami
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
